The Progression of Alzheimer's Disease

January 21, 2022

The Progression of Alzheimer's Disease

Alzheimer’s disease (AD) is a slowly progressing, irreversible neurodegenerative brain disease with a long preclinical phase (up to 20 years) and an average clinical duration of 8 to 10 years. The progression of AD is accompanied by changes to the brain that serve as disease biomarkers.

Normal aging vs. Alzheimer’s disease

Alzheimer’s disease symptoms often start subtly. People with early Alzheimer’s disease (and their families) may mistake the early signs for normal aging and put off going to a doctor.
Disease progression typically spans several stages. These stages include preclinical Alzheimer’s disease, mild cognitive impairment (MCI) due to Alzheimer’s disease, and Alzheimer’s disease dementia varying from mild to severe.

  • Preclinical Alzheimer’s disease: individuals with evidence of Alzheimer’s disease pathology who have no clinical symptoms.
  • MCI due to Alzheimer’s disease: evidence of Alzheimer’s disease pathology along with impairment in 1 or more cognitive domains that do not interfere with daily functioning.
  • Alzheimer’s disease dementia (mild, moderate, severe): when cognitive abilities further decline and cause impairment in functional abilities.

MCI due to Alzheimer’s disease is a critical stage of the disease continuum

During this stage, clinicians may be able to detect very early features of Alzheimer’s disease compared to other causes of memory loss or other forms of cognitive impairment. These features can be detected using validated tools such as Mini-Cog, General Practitioner Assessment of Cognition (GPCOG), Memory Impairment Screen (MIS), and Montreal Cognitive Assessment (MoCA).7-9

The time between MCI due to AD and AD dementia is limited

The rate of cognitive decline increases sharply in the years before dementia. Since MCI is the earliest stage of Alzheimer’s disease with observable symptoms, this leaves limited time between diagnosis and dementia—with estimates ranging from 2 to 6 years.1,5,6.
Patients with MCI due to AD have been shown to convert to AD dementia at an annual rate of 31%.

Link to Story

The Role of Caregivers in Assisted Living: Compassion and Expertise At Highland Village

Assisted living communities provide a valuable and supportive environment for seniors who require assistance with daily activities but still desire independence and a high quality of life. At the heart of these communities are the caregivers, individuals who play a pivotal role in ensuring the well-being and comfort of residents. In this blog, we will […]

Read More
Nutrition and Wellness: How Assisted Living Supports Healthy Aging At Highland Village

Aging is a natural part of life, but it's essential to age gracefully and maintain one's health and well-being. Nutrition plays a pivotal role in healthy aging, and assisted living facilities are increasingly recognizing the importance of providing top-notch nutrition and wellness programs to their residents. In this blog, we'll explore how assisted living supports […]

Read More
The Impact of Architecture and Design in Alzheimer's Care Homes

Alzheimer's disease is a progressive neurological disorder that affects memory, cognitive function, and behavior. As the number of individuals diagnosed with Alzheimer's continues to rise, the importance of creating supportive and safe environments for those affected by the disease becomes increasingly evident. Architecture and design play a crucial role in Alzheimer's care homes, as they […]

Read More

Phone

281-208-5876

Email


© Copyright 2023. 
All Rights Reserved.

Village Green is a Licensed and Certified Alzheimer's Care Home.